Showing results (31-40 of 143) with videos related to
Sort By:
Pageof 15
Trends in Immunology|March 30, 2002
Cross-priming versus cross-tolerance: are two signals enough?Thomas Blankenstein, Thomas SchülerAdvances in Cancer Research|January 9, 2004
Chemical carcinogens as foreign bodies and some pitfalls regarding cancer immune surveillanceThomas Blankenstein, Zhihai QinJournal of Immunology (Baltimore, Md. : 1950)|April 23, 2003
Cutting edge: CD8+ effector T cells reject tumors by direct antigen recognition but indirect action on host cellsThomas Schüler, Thomas BlankensteinEuropean Journal of Immunology|July 28, 2009
Making and circumventing tolerance to cancerThomas Kammertoens, Thomas BlankensteinJournal for Immunotherapy of Cancer|June 3, 2025
Enhanced mutanome analysis towards the induction of neoepitope-reactive T-cell responses for personalized immunotherapy of pancreatic cancerMichael Volkmar, Dana Hoser, Claudia Lauenstein, et al.World Journal of Urology|July 6, 2005
Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cellsBernhard Frankenberger, Sybille Regn, Christiane Geiger, et al.Molecular Medicine (Cambridge, Mass.)|December 28, 2012
High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccinationHeike Pohla, Alexander Buchner, Birgit Stadlbauer, et al.The Journal of Experimental Medicine|November 19, 2003
Tumor rejection by modulation of tumor stromal fibroblastsThomas Schüler, Sandra Körnig, Thomas BlankensteinTrends in Molecular Medicine|May 11, 2005
Immunotherapy: target the stroma to hit the tumorThomas Kammertoens, Thomas Schüler, Thomas BlankensteinThe Journal of Experimental Medicine|August 25, 2017
Human TCR-MHC coevolution after divergence from mice includes increased nontemplate-encoded CDR3 diversityXiaojing Chen, Lucia Poncette, Thomas BlankensteinPageof 15